Effect of supplementation of chromium in glucose of diabetic patients
- Conditions
- Type 2 Diabetes MellitusC18.452.394.750.149
- Registration Number
- RBR-79nxr8
- Lead Sponsor
- niversidade Feral do Rio Grande do Norte
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Volunteers diagnosed with type two diabetes mellitus according to the criteria of the American Diabetes Association two thousand and eleven; both genders; presenting glycated hemoglobin greater than or equal to seven percent; not in use of insulin; age between thirty and seventy years; not have taked mineral vitamin supplement in the last three months
Volunteers taking insulin and / or corticosteroids; showing endocrinopathy (cushin syndrome; acromegaly; hyper or uncontrolled hypothyroidism); kidney disease; cancer; infection and anemia; pregnant women; lactating women
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in glycemic control (fasting blood glucose, postprandial blood glucose and glycated hemoglobin), after 4 months of supplementation with chromium picolinate compared the differences between the groups;The glycemic profile (fasting blood glucose, postprandial blood glucose and glycated hemoglobin) showed improvement after 4 months of supplementation with chromium picolinate, compared the differences between the groups
- Secondary Outcome Measures
Name Time Method Improvement in lipid profile (total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides), after 4 and 8 months of supplementation with chromium picolinate compared the differences between the groups;No improvement was found in the lipid profile (total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides)after 4 months of supplementation with chromium picolinate, compared the differences between the groups